A detailed history of Central Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Central Trust CO holds 5,939 shares of NVO stock, worth $623,951. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,939
Previous 5,898 0.7%
Holding current value
$623,951
Previous $841,000 15.93%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$119.07 - $145.42 $4,881 - $5,962
41 Added 0.7%
5,939 $707,000
Q1 2024

Apr 24, 2024

SELL
$102.11 - $135.92 $7,351 - $9,786
-72 Reduced 1.21%
5,898 $757,000
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $2,984 - $3,585
-34 Reduced 0.57%
5,970 $617,000
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $287,916 - $631,743
3,166 Added 111.56%
6,004 $546,000
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $88,752 - $98,237
569 Added 25.08%
2,838 $459,000
Q1 2023

Apr 19, 2023

BUY
$132.34 - $159.14 $529 - $636
4 Added 0.18%
2,269 $361,000
Q4 2022

Jan 26, 2023

BUY
$102.55 - $135.33 $1,538 - $2,029
15 Added 0.67%
2,265 $0
Q3 2021

Oct 19, 2021

BUY
$84.42 - $106.62 $1,350 - $1,705
16 Added 0.72%
2,250 $216,000
Q2 2021

Jul 23, 2021

BUY
$67.66 - $84.76 $20,298 - $25,428
300 Added 15.51%
2,234 $187,000
Q4 2020

Jan 29, 2021

BUY
$63.89 - $73.8 $100,882 - $116,530
1,579 Added 444.79%
1,934 $135,000
Q1 2020

Apr 17, 2020

SELL
$49.46 - $64.78 $2,473 - $3,239
-50 Reduced 12.35%
355 $21,000
Q2 2019

Jul 12, 2019

BUY
$46.79 - $52.47 $2,339 - $2,623
50 Added 14.08%
405 $0
Q4 2018

Jan 08, 2019

SELL
$41.54 - $47.25 $27,541 - $31,326
-663 Reduced 65.13%
355 $16,000
Q3 2018

Oct 04, 2018

SELL
$46.76 - $51.24 $561 - $614
-12 Reduced 1.17%
1,018 $0
Q1 2018

Apr 04, 2018

SELL
$48.49 - $58.14 $27,154 - $32,558
-560 Reduced 35.22%
1,030 $0
Q4 2017

Jan 23, 2018

SELL
$47.53 - $53.73 $1,663 - $1,880
-35 Reduced 2.15%
1,590 $0
Q3 2017

Oct 17, 2017

BUY
$41.15 - $49.22 $66,868 - $79,982
1,625
1,625 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.